Business Description
Wave Life Sciences is a clinical-stage biotech company focused on developing RNA-based medicines to treat a range of serious diseases, from rare genetic conditions to more common disorders like obesity and liver disease. Its proprietary drug development platform combines chemical innovation with human genetics research to build a pipeline that includes treatments for Duchenne muscular dystrophy, Huntington's disease, and alpha-1 antitrypsin deficiency, among others. The company works alongside major pharmaceutical partners, including GlaxoSmithKline and Takeda, to advance these therapies toward patients. Founded in 2012 and headquartered in Singapore, Wave Life Sciences continues to grow its portfolio across multiple disease areas.
